Harnessing AI and Real-World Evidence to Advance Alzheimer’s Screening and Equitable Access
Presented by MAPS
In this educational webinar, experts from Komodo Health and Medscape will present findings from a recent joint research initiative. We'll explore how AI-driven analysis of real-world data (RWD) can illuminate trends in Alzheimer’s screening, testing, and treatment—and critically, where inequities remain.
Given emerging treatments create opportunities to improve patient care, the session will offer a complementary perspective highlighting how the approval of new therapies drives both information-seeking among healthcare professionals (HCPs) and opportunities for funding for external education. Ultimately, targeted HCP education influences knowledge, confidence, and clinical practice, underscoring its vital role in improving equitable outcomes.
*Please Note: LIVE WEBINAR is open to the public. ON-DEMAND recording will be available to MAPS members after the event. Non-Members for a fee.
Original Webinar took place: Friday, December 5, 2025 | 10-11 AM EST
DOWNLOAD THE LIVE WEBINAR
READ THE WRAP UP ARTICLE

Rob Adamoski
Vice President, Medical Affairs
Corcept Therapeutics
.png)
Tabby Khan, MD,MPH
Senior Director, Analytics
Komodo Health

Katie Lucero, PhD
Chief Impact Officer
Medscape